---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-290302"
form_type: "8-K"
ticker: "AMLX"
cik: "0001658551"
company_name: "Amylyx Pharmaceuticals, Inc."
filed_at: "2023-12-07T23:59:59+00:00"
generated_at: "2026-06-07T16:14:39.243291+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Amylyx CCO Margaret Olinger to depart Dec 31, 2023; search underway

## Summary
- Margaret Olinger, Chief Commercial Officer, will leave Amylyx effective end of day Dec 31, 2023.
- Company has initiated a search for a new Chief Commercial Officer.
- Olinger's departure is not related to any disagreement with Amylyx regarding operations, policies, or practices.

## SEC filing metadata
- accession: 0001193125-23-290302
- form_type: 8-K
- ticker: AMLX
- cik: 0001658551
- company_name: Amylyx Pharmaceuticals, Inc.
- filed_at: 2023-12-07T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1658551/000119312523290302/0001193125-23-290302-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1658551/000119312523290302/d646901d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-290302
- JSON: https://secwatch.observer/filing/0001193125-23-290302.json
- Plain text: https://secwatch.observer/filing/0001193125-23-290302.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.